UNCOMMON SIDE EFFECTS OF SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CANCER: CASE REPORT

SUMMARY – Sunitinib is an orally administered multikinase inhibitor. This therapy can provoke uncommon side effects such as pancytopenia, tumor lysis syndrome, cardiac disorders, thromboembolic incidents, intestinal perforation, pancreatitis, acute renal failure, etc. We report a case of a 63-year-o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Acta Clin Croat
Asıl Yazarlar: Šeparović, Robert, Pavlović, Mirjana, Silovski, Tajana, Silovski, Hrvoje, Tečić Vuger, Ana
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2018
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536270/
https://ncbi.nlm.nih.gov/pubmed/31168192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20471/acc.2018.57.03.22
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller